| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.07T | 1.08T | 1.14T | 943.98B | 849.07B |
| Gross Profit | 257.00B | 255.25B | 251.48B | 211.96B | 185.45B |
| EBITDA | 62.69B | 90.30B | 64.70B | 96.53B | 74.47B |
| Net Income | 7.72B | 32.74B | 7.71B | 44.05B | 26.76B |
Balance Sheet | |||||
| Total Assets | 1.26T | 1.20T | 1.15T | 1.09T | 1.03T |
| Cash, Cash Equivalents and Short-Term Investments | 111.13B | 104.46B | 97.48B | 88.78B | 99.52B |
| Total Debt | 248.28B | 171.00B | 171.74B | 111.25B | 136.54B |
| Total Liabilities | 613.83B | 573.39B | 571.95B | 528.09B | 525.76B |
| Stockholders Equity | 640.68B | 619.77B | 569.26B | 551.39B | 490.70B |
Cash Flow | |||||
| Free Cash Flow | -34.92B | 25.91B | -15.18B | -15.18B | 24.29B |
| Operating Cash Flow | 12.76B | 65.37B | 21.37B | 21.37B | 64.13B |
| Investing Cash Flow | -49.48B | -43.27B | -37.28B | -37.28B | -43.73B |
| Financing Cash Flow | 41.91B | -17.21B | 21.68B | 21.68B | -7.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥261.07B | 14.24 | ― | 1.65% | 14.49% | -21.17% | |
72 Outperform | ¥691.08B | 18.72 | 5.14% | 3.31% | -1.14% | -19.79% | |
71 Outperform | ¥475.50B | 26.32 | 5.25% | 2.13% | -2.23% | 130.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥681.43B | 29.16 | 11.66% | 1.03% | 10.11% | 41.98% | |
55 Neutral | ¥514.96B | -6.48 | 1.88% | 6.16% | 1.98% | -48.28% | |
54 Neutral | ¥601.98B | 11.29 | 4.83% | 2.95% | -2.67% | -85.21% |